Cannara Biotech (OTCMKTS:CNBTF) Trading Down 3.9% – Should You Sell?

Cannara Biotech (OTCMKTS:CNBTF) shares fell 3.9% during trading on Tuesday . The company traded as low as $1.3850 and last traded at $1.3880. 24,120 shares changed hands during trading, a decline of 27% from the average session volume of 33,127 shares. The stock had previously closed at $1.4440.

Cannara Biotech Price Performance

The stock has a 50 day moving average price of $1.26 and a two-hundred day moving average price of $1.28.

Cannara Biotech Holdings Inc (OTCMKTS:CNBTF) is a biotechnology and natural health company focused on the development, production and distribution of plant-derived formulations, including cannabinoid-based products. Headquartered in Canada, the company integrates research and development with large-scale extraction and formulation processes to serve the pharmaceutical, cosmetic and wellness industries.

The company’s offerings comprise high-purity botanical extracts, nutraceutical ingredients and cosmetic actives developed using proprietary extraction and purification techniques.